Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome
- PMID: 18063948
Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome
Abstract
Objective: To analyze the clinical and metabolic characteristics of large-scale Chinese women with polycystic ovary syndrome (PCOS).
Design: Retrospective study.
Setting: Hospital-based IVF center.
Patient(s): Patients with PCOS.
Methods: In the present study, one thousand and forty PCOS patients were selected from women who visited the Reproductive Medicine Center at Shandong Provincial Hospital Shandong University between January 2002 and December 2006. All the patients had been performed a 75 g OGTT. Clinical characteristics, serum hormonal levels, glucose levels, insulin levels and lipid profiles were reviewed.
Interventions: An oral glucose tolerance test and insulin release test were performed for each woman. After overnight fasting, blood samples were collected to determine fasting blood glucose, blood glucose and insulin (30 min, 60 min, 120 min, 180 min) after digesting 75 g glucose, luteotrophic hormone (LH), follicle-stimulating hormone (FSH), testosterone (T), prolactin (PRL), estradiol (E2), and blood lipid levels.
Main outcome measures: Height, weight, waistline, hip circumference, F-G grade for hirsutism, gonadal hormone results, blood lipid level, blood glucose tolerance, each-moment insulin level, and family history were determined.
Results: (i) The presence of oligomenorrhea was 62.6% while amenorrhea was 19.71%. Menstrual disorder of all the adult patients could be traced back to their adolescent menarche. There were 450 obesity cases of which 259 patients were central obesity. The incidence of acanthosis nigricans was 15.19%, 65.19% with obesity. (ii) Cholesterol (4.8 +/- 0.98 vs 4.61 +/- 0.86) and LDL (3.80 +/- 6.92 vs 2.88 +/- 1.01) were both significantly higher in the obesity patients than the non obesity patients. (iii) 173 patients were diagnosed as diabetes mellitus (DM), 179 IGT, 27 IFG and 9 (IFG and IGT). Those women with plasma glucose values abnormality of 0, 30 min, 60 min, 120 min, 180 min were 19 cases 0.98% (19/173), 74 cases 42.77% (74/173), 110 cases 63.58% (110/173), 42 cases 24.28% (42/173) and 12 cases 6.94% (12/173) respectively. Ten (10/173) patients would have been undetected if fasting plasma glucose levels were not evaluated, while omission of 30 min, 60 min, 120 min, or 180 min plasma glucose levels would have resulted in 16 cases (16/173), 50 cases (50/173), 28 cases (28/173) and 1 case (1/173) being missed respectively. If we took three times blood samples to evaluate plasma glucose levels, 39 cases (39/173) (0 min + 30 min +60 min), 102 cases (0 min + 30 min + 120 min), 21 cases (0 min + 30 min + 180 min), 34 cases (0 min + 60 min + 120 min), 45 cases (0 min + 60 min + 180 min), 123 cases (0 min + 120 min + 180 min) would be missed. Compared AUC of plasma glucose and insulin in 5 times with 3 times (0 min + 30 min + 60 min), the differences were statistically significant. Body mass index (BMI) was positively correlated with HOMA-IR (r = 0.29987 (P<0.01) as well as WHR (r = 0.12441, P<0.0001).
Conclusions: (i) The prevalence rate of obesity was higher in PCOS. The state of obesity had a positive relation with insulin resistance. (ii) The prevalence rate of lipid profiles abnormality in obesity group was higher than in non-obesity. (iii) OGTT was the essential examination for all the PCOS patients.
Similar articles
-
Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.Fertil Steril. 2008 Oct;90(4):1139-43. doi: 10.1016/j.fertnstert.2007.07.1375. Epub 2007 Sep 24. Fertil Steril. 2008. PMID: 17889857
-
Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.J Soc Gynecol Investig. 2005 Feb;12(2):129-34. doi: 10.1016/j.jsgi.2004.09.003. J Soc Gynecol Investig. 2005. PMID: 15695109
-
[Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].Zhonghua Fu Chan Ke Za Zhi. 2007 Nov;42(11):756-60. Zhonghua Fu Chan Ke Za Zhi. 2007. PMID: 18307903 Chinese.
-
Type 2 diabetes and the polycystic ovary syndrome.Minerva Ginecol. 2004 Feb;56(1):41-51. Minerva Ginecol. 2004. PMID: 14973409 Review.
-
Polycystic ovary syndrome and type 2 diabetes mellitus.Minerva Ginecol. 2004 Feb;56(1):53-62. Minerva Ginecol. 2004. PMID: 14973410 Review.
Cited by
-
Effect of Wenshentiaojing Decoction on Hormone Level and Follicular Number in Patients with Menstrual Disorder of Polycystic Ovary Syndrome.Evid Based Complement Alternat Med. 2021 Nov 29;2021:4975867. doi: 10.1155/2021/4975867. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34880919 Free PMC article.
-
Distribution of normal and pathological OGTTs among pregnant population and non-pregnant women with PCOS - the cross-sectional study.Medicine (Baltimore). 2021 Sep 17;100(37):e27232. doi: 10.1097/MD.0000000000027232. Medicine (Baltimore). 2021. PMID: 34664864 Free PMC article.
-
Alterations of Sphingolipid Metabolism in Different Types of Polycystic Ovary Syndrome.Sci Rep. 2019 Mar 1;9(1):3204. doi: 10.1038/s41598-019-38944-6. Sci Rep. 2019. PMID: 30824725 Free PMC article.
-
Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet.J Ovarian Res. 2023 Jun 5;16(1):109. doi: 10.1186/s13048-023-01193-3. J Ovarian Res. 2023. PMID: 37277785 Free PMC article.
-
An association study between USP34 and polycystic ovary syndrome.J Ovarian Res. 2015 May 15;8:30. doi: 10.1186/s13048-015-0158-y. J Ovarian Res. 2015. PMID: 25975428 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical